More Globe Newswire

View Older Stories View Newer Stories

May 21, 2026 06:01PM Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting
May 21, 2026 06:00PM Samba TV Launches Project Gravity, an Independent Data Activation Platform for the Agentic Era
May 21, 2026 06:00PM Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
May 21, 2026 06:00PM Prairie Provident Reports on AGM Voting Results
May 21, 2026 05:51PM Perspective Therapeutics to Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in Melanoma
May 21, 2026 05:49PM Mountain America Credit Union Ranked Among USA Today’s Top 10 Workplaces for Third Consecutive Year
May 21, 2026 05:41PM Modaxo Enters into Agreement to Acquire the Public Transit Business from Conduent
May 21, 2026 05:40PM nVent to Participate in Upcoming Investor Conference
May 21, 2026 05:39PM Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer at
May 21, 2026 05:30PM Peace Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
May 21, 2026 05:30PM Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
May 21, 2026 05:29PM Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
May 21, 2026 05:21PM Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors
May 21, 2026 05:15PM Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering
May 21, 2026 05:13PM Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations
May 21, 2026 05:10PM Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026
May 21, 2026 05:07PM Equus Announces First Quarter Net Asset Value
May 21, 2026 05:06PM Whale Dynamic Joins Hitch Open World AI Championships as Official Mapping Technology Partner, Delivering Centimeter-Accurate HD Map of Tianmen Mountain for 2026 Racing Season
May 21, 2026 05:05PM Remix Therapeutics Announces Positive Data from Phase 1/2 ARIA Study of First-in-Class MYB mRNA Degrader, REM-422, in Patients with Adenoid Cystic Carcinoma (ACC) at the American Society of Clinical O
May 21, 2026 05:05PM Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology
May 21, 2026 05:05PM North American Construction Group Ltd. Announces Voting Results of Annual and Special Meeting of Shareholders
May 21, 2026 05:02PM Imperial Announces Voting Results for the Election of Directors
May 21, 2026 05:02PM Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data for Annamycin
May 21, 2026 05:01PM Lynozyfic® (linvoseltamab) Monotherapy Demonstrates Deep and Rapid Responses in All Treated Patients with Second-Line-Plus Systemic Amyloid Light Chain Amyloidosis
May 21, 2026 05:01PM Akari Therapeutics Reports Breakthrough Preclinical Data Demonstrating Synergistic Activity of AKTX-101 with KRAS Inhibition in KRAS-Mutated Pancreatic Cancer Models
May 21, 2026 05:01PM Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data
May 21, 2026 05:00PM AerSale Announces Participation at the 2026 Jefferies Aftermarket MRO Virtual Summit
May 21, 2026 05:00PM Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026
May 21, 2026 05:00PM TruGolf Reports First Quarter 2026 Results
May 21, 2026 05:00PM HiberCell to Present Preliminary Results from the Phase 1b Trial of GCN2 Activator HC-7366 when Combined with WELIREG® (belzutifan) for the Treatment of Late-Line Clear Cell Renal Cell Carcinoma (ccR
May 21, 2026 05:00PM Canadian Net REIT Announces 2026 First-Quarter Results and a Distribution Increase
May 21, 2026 05:00PM Asher Biotherapeutics Announces Two Presentations at the ASCO 2026 Annual Meeting Highlighting Clinical Progress Across Its CD8-Targeted Cytokine Pipeline
May 21, 2026 05:00PM Zodiac Partners II, LLC Provides an Update to its Previously Announced $46 million Tender Offer to Acquire Destination XL Group, Inc. for $0.82 Per Share in Cash
May 21, 2026 05:00PM NVIDIA Announces Upcoming Events for Financial Community
May 21, 2026 05:00PM Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC
May 21, 2026 05:00PM Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting
May 21, 2026 05:00PM Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy
May 21, 2026 05:00PM Cardiff Oncology Announces Webcast to Discuss Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC
May 21, 2026 05:00PM Navient declares second quarter common stock dividend
May 21, 2026 05:00PM BlossomHill Therapeutics to Present Preliminary Results From Phase 1 Dose Escalation/Backfill Cohorts in Phase 1/2 SOLARA Trial of OMNI-EGFR Inhibitor, BH-30643, in Advanced EGFR-mutant NSCLC at the 2
May 21, 2026 05:00PM Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting
May 21, 2026 05:00PM Rgenta Therapeutics Presents Positive Preliminary Data from Ongoing Phase 1a/b Clinical Trial of RGT-61159 in Patients with Adenoid Cystic Carcinoma and Colorectal Cancer at the 2026 ASCO Meeting
May 21, 2026 05:00PM Legend Biotech Announces Presentations at ASCO 2026
May 21, 2026 05:00PM Genmab to Highlight Advances Across Its Oncology Portfolio at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2026 Congress
May 21, 2026 04:55PM Banco Comercial Português, S.A., announces the commencement of duties of the Board of Directors for the 2026-2029 four-year term
May 21, 2026 04:47PM Banqup delivers 40,3% y/y growth in subscription revenue in Q1 2026
May 21, 2026 04:45PM The Math Underlying the Success of Tort Reforms – Florida Property Insurance and Beyond
May 21, 2026 04:45PM AMSC to Report Fourth Quarter and Fiscal Year 2025 Financial Results on May 27, 2026
May 21, 2026 04:45PM CVB Financial Corp. Names George A. Borba Jr. Chairman of the Board; Prior Chairman Hal W. Oswalt Transitions to Vice Chairman
May 21, 2026 04:38PM Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group
View Newer Stories View Older Stories